Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.
The Company’s research and development efforts include an ongoing collaboration a leading pediatric academic medical center.
Our Core Strategy
- Patient Focus
- Developing best-in-class therapies that are transformative to children and adults with pediatric onset life altering diseases
- Collaborating with patients, families, and advocacy groups to increase awareness of the genomic-basis of disease, support research, and improve access to therapies
- Genomic Medicine Platform
- Having unparalleled insight into the genetic drivers of disease
- Pushing the boundaries of medicine and technology to develop new and differentiated therapies
- Applying broad capabilities in genomically guided drug development to derisk development programs and improve clinical response rates
- Proven Management Team
- Experienced and successful drug developers
- Demonstrated leadership in making novel therapies available for patient care